TGA Approval

ICLUSIG ponatinib (as hydrochloride) 30 mg film-coated tablet bottle (374492)

ARTG ID

374492

ARTG Name

ICLUSIG ponatinib (as hydrochloride) 30 mg film-coated tablet bottle

Sponsor

Takeda Pharmaceuticals Australia Pty Ltd

ARTG Date

September 16, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-CMI-02146-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-02267-1

Ingredient Name

ponatinib hydrochloride

Empowering clinical research with data-driven insights and AI-powered tools.

ICLUSIG ponatinib (as hydrochloride) 30 mg film-coated tablet bottle (374492) - TGA 批准文号 | MedPath